REG - TA Associates Mgmt Adv Medical Solutns. - No Intention to Make an Offer for AMS

Advanced Medical SolutionsAnnouncement

Yesterday 19:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260515:nRSO6088Ea&default-theme=true

RNS Number : 6088E  TA Associates Management, L.P.  15 May 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS
AND MERGERS (THE "CODE")

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

 

15 May 2026

 

No intention to make an offer for AMS

 

Further to the announcement on 18 April 2026 by Advanced Medical Solutions
Group plc ("AMS") that funds affiliated with TA Associates (UK), LLP
(together, "TA") were considering a possible offer for the entire issued and
to be issued share capital of AMS, TA today confirms that it does not intend
to make an offer for AMS.

TA is grateful for the engagement with the AMS Board and management team and
would like to thank them for their time and consideration of this potential
transaction.

This is a statement to which Rule 2.8 of the Code applies. Accordingly, TA
and any person(s) acting in concert with it will, except with the consent of
the Panel on Takeovers and Mergers (the "Takeover Panel"), be bound by the
restrictions set out in Rule 2.8 of the Code. Under Note 2 on Rule 2.8 of the
Code, TA, and any person(s) acting in concert with it, reserves the right to
set the restrictions in Rule 2.8 of the Code aside in the following
circumstances:

a)   with the agreement of the board of Directors of AMS;

 

b)   following the announcement of a firm intention to make an offer for AMS
by, or on behalf of, a third party;

 

c)   following the announcement by AMS of a Rule 9 waiver proposal (as
described in Note 1 of the Notes on Dispensations from Rule 9 of the Code), or
a reverse takeover (as defined by the Code); or

 

d)   where the Takeover Panel has determined that there has been a material
change in circumstances.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  OUPVELFFQELFBBK



            Copyright 2019 Regulatory News Service, all rights reserved